Frontiers in Cellular and Infection Microbiology (Aug 2022)

Ferrets as a model for tuberculosis transmission

  • Tuhina Gupta,
  • Naveen Somanna,
  • Thomas Rowe,
  • Thomas Rowe,
  • Monica LaGatta,
  • Shelly Helms,
  • Simon Odera Owino,
  • Tomislav Jelesijevic,
  • Stephen Harvey,
  • Wayne Jacobs,
  • Thomas Voss,
  • Kaori Sakamoto,
  • Cheryl Day,
  • Christopher Whalen,
  • Russell Karls,
  • Biao He,
  • S. Mark Tompkins,
  • Abhijeet Bakre,
  • Ted Ross,
  • Frederick D. Quinn

DOI
https://doi.org/10.3389/fcimb.2022.873416
Journal volume & issue
Vol. 12

Abstract

Read online

Even with the COVID-19 pandemic, tuberculosis remains a leading cause of human death due to a single infectious agent. Until successfully treated, infected individuals may continue to transmit Mycobacterium tuberculosis bacilli to contacts. As with other respiratory pathogens, such as SARS-CoV-2, modeling the process of person-to-person transmission will inform efforts to develop vaccines and therapies that specifically impede disease transmission. The ferret (Mustela furo), a relatively inexpensive, small animal has been successfully employed to model transmissibility, pathogenicity, and tropism of influenza and other respiratory disease agents. Ferrets can become naturally infected with Mycobacterium bovis and are closely related to badgers, well known in Great Britain and elsewhere as a natural transmission vehicle for bovine tuberculosis. Herein, we report results of a study demonstrating that within 7 weeks of intratracheal infection with a high dose (>5 x 103 CFU) of M. tuberculosis bacilli, ferrets develop clinical signs and pathological features similar to acute disease reported in larger animals, and ferrets infected with very-high doses (>5 x 104 CFU) develop severe signs within two to four weeks, with loss of body weight as high as 30%. Natural transmission of this pathogen was also examined. Acutely-infected ferrets transmitted M. tuberculosis bacilli to co-housed naïve sentinels; most of the sentinels tested positive for M. tuberculosis in nasal washes, while several developed variable disease symptomologies similar to those reported for humans exposed to an active tuberculosis patient in a closed setting. Transmission was more efficient when the transmitting animal had a well-established acute infection. The findings support further assessment of this model system for tuberculosis transmission including the testing of prevention measures and vaccine efficacy.

Keywords